Local dose-dense chemotherapy for triple-negative breast cancer via minimally invasive implantation of 3D printed devices
Dose-dense chemotherapy is the preferred first-line therapy for triple-negative breast cancer (TNBC), a highly aggressive disease with a poor prognosis. This treatment uses the same drug doses as conventional chemotherapy but with shorter dosing intervals, allowing for promising clinical outcomes wi...
Main Authors: | Noehyun Myung, Hyun-Wook Kang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-02-01
|
Series: | Asian Journal of Pharmaceutical Sciences |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1818087624000011 |
Similar Items
-
Negative Relationship between Post-Treatment Stromal Tumor-Infiltrating Lymphocyte (TIL) and Survival in Triple-Negative Breast Cancer Patients Treated with Dose-Dense Dose-Intense NeoAdjuvant Chemotherapy
by: Sylvie Giacchetti, et al.
Published: (2022-03-01) -
Possible surrogate marker for an effective dose-dense chemotherapy in treating ovarian cancer
by: Chueh-Yi Huang, et al.
Published: (2016-06-01) -
Targeted Liposomal Chemotherapies to Treat Triple-Negative Breast Cancer
by: Yingnan Si, et al.
Published: (2021-07-01) -
Effectiveness of adjuvant chemotherapy for elderly patients with triple-negative breast cancer
by: Qiusheng Guo, et al.
Published: (2023-05-01) -
Hexachlorobenzene as a differential modulator of the conventional and metronomic chemotherapy response in triple negative breast cancer cells
by: Yamila Sanchez, et al.
Published: (2024-03-01)